The DOI matches its Crossref record.
Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis
Abstract
Objective. To determine the frequency, clinical associations, and any major histocompatibility complex correlations of antifibrillarin antibodies in patients with systemic sclerosis (SSc). Methods. Antifibrillarin antibodies were determined by indirect immunofluorescence, immunoblotting, and immunoprecipitation, and HLA class II alleles by DNA oligotyping, in a large cohort of SSc patients. Results. Antifibrillarin was found in 8% of 335 SSc sera and was significantly more common in blacks (16%) than whites (5%), in males (33%) than females (14%), and in patients with cardiac, renal, or gut involvement. The HLA class II haplotype DRB1*1302, DQB1*0604 was found significantly more frequently in SSc patients with antifibrillarin compared with racematched normal controls and 260 SSc patients without antifibrillarin. In addition, 1 or more of the HLA–DQB1 alleles *0604, *0301, *0602, and/or *0302 was found in all antifibrillarin‐positive patients, and 62% of the antifibrillarin‐positive patients had 2 of these HLA–DQB1 alleles, a highly significant difference from both race‐matched normal controls and antifibrillarin‐negative SSc patients. Conclusion. Antifibrillarin, although an infrequent nucleolar autoantibody, is a marker for severe SSc, especially in blacks and males, and is strongly associated with a unique HLA haplotype, as well as with combinations of certain HLA–DQB1 alleles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Review: Environmental exposure to mercury and its toxicopathologic implications for public health
Tchounwou, P. B., Ayensu, W. K., Ninashvili, N., & Sutton, D. (2003) · Environmental Toxicology · doi:10.1002/tox.10116 · Cited by 1,298
Damoiseaux, J., Andrade, L. E. C., Carballo, O. G., Conrad, K., Francescantonio, P. L. C., Fritzler, M. J., Garcia de la Torre, I., Herold, M., Klotz, W., Cruvinel, W. D. M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214436 · Cited by 378
Self-citationUfd2, a Novel Autoantigen in Scleroderma, Regulates Sister Chromatid Separation
Spinette, S., Lengauer, C., Mahoney, J. A., Jallepalli, P. V., Wang, Z., Casciola-Rosen, L., & Rosen, A. (2004) · Cell Cycle · doi:10.4161/cc.3.12.1345 · Cited by 309
Reveille, J. D., Fischbach, M., McNearney, T., Friedman, A. W., Aguilar, M. B., Lisse, J., Fritzler, M. J., Ahn, C., & Arnett, F. C. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.20268 · Cited by 277
Self-citationAutoantibodies in systemic sclerosis
Mehra, S., Walker, J., Patterson, K., & Fritzler, M. J. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.05.011 · Cited by 252
Self-citation
Metadata
- Authors
- Arnett, F. C., Reveille, J. D., Goldstein, R., Pollard, K. M., Leaird, K., Smith, E. A., Leroy, E. C., & Fritzler, M. J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1996-07
- Volume
- 39
- Issue
- 7
- Pages
- 1151-1160
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2120465956
- Cited by
- 169
- References
- 0
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. https://app.cochat.ai/papers/10.1002/art.1780390712
- The paper
- Arnett, F. C., Reveille, J. D., Goldstein, R., Pollard, K. M., Leaird, K., Smith, E. A., Leroy, E. C., & Fritzler, M. J. (1996). Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780390712
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.